Journal of Pharma and Drug Innovation

Now Accepting Manuscripts Annual (One issue per year) Open Access Single-Blind Peer Review
Editorial & Review Timeline
3 - 4 Days Initial Quality Review
20 Days Peer Evaluation Summary
30 - 45 Days Complete Editorial Processing Time

Biologics, Biosimilars, and Immunotherapy

Biological therapeutics and immune-based treatments have become important components of modern healthcare and pharmaceutical research. Biologics and biosimilars offer new treatment possibilities for complex diseases, including cancer, autoimmune disorders, and infectious diseases. Immunotherapy approaches help strengthen or modify the immune system to improve therapeutic outcomes. The journal supports research related to the development, evaluation, and clinical application of biologics and advanced therapeutic products.